However, there is still a gap between clinical evidence and daily practice, as the therapeutic goal is difficult to achieve and maintain throughout disease progression This is due to the numerous barriers involved in diabetes management, such as the occurrence and fear of hypoglycemic episodes, the complexity of treatment and the daily routine and the need for frequent monitoring and adjustment of insulin doses, factors that affect the quality of life of adolescents(4). Here, INS is linked to diabetes mellitus.